The role of nuclear receptor co-activator 4 in erythropoiesis (Reply to Nai et al.)
Naiara Santana-Codina, Sebastian Gableske, Mark D. Fleming, J. Wade Harper, Alec C. Kimmelman, Joseph D. Mancias
Haematologica December 2019 104: e585-e586; doi:10.3324/haematol.2019.235226

Author Affiliations

  1. Naiara Santana-Codina1,
  2. Sebastian Gableske1,
  3. Mark D. Fleming2,
  4. J. Wade Harper3⇑,
  5. Alec C. Kimmelman4⇑ and
  6. Joseph D. Mancias1⇑
  1. 1Division of Genomic Stability and DNA Repair, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA;
  2. 2Department of Pathology, Boston Children’s Hospital and Harvard Medical School, 320 Longwood Avenue, Boston, MA
  3. 3Department of Cell Biology, Harvard Medical School, Boston, MA and
  4. 4Department of Radiation Oncology, Perlmutter Cancer Center, New York University School of Medicine, New York, NY, USA
  1. Correspondence: JOSEPH D. MANCIAS: Joseph_Mancias{at}dfci.harvard.edu
  2. Correspondence: ALEC C. KIMMELMAN: Alec.Kimmelman{at}nyumc.org
  3. Correspondence: J. WADE HARPER: wade_harper{at}hms.harvard.edu

Data supplements

Back to top
Email
Print
Citation Tools

Jump To

What about you?
Tell us your interests and get all the new contents of Haematologica in advance